PubHawk
N Engl J Med November 2006 PMID 17108342

Normalization of hemoglobin level in patients with chronic kidney disease and anemia.

Tilman B Drüeke, Francesco Locatelli, Naomi Clyne, Kai-Uwe Eckardt, Iain C Macdougall, Dimitrios Tsakiris, Hans-Ulrich Burger, Armin Scherhag

Full text PDF Download social card

Mentions

15
Peak: 4 in Jan 2019
across 4 sources since Jan 2019

Extended reach

18,568
potential audience

Total likes

57

Video views

3,741

Mentions per month

Jan 2019 – Apr 2024

Where it's discussed

  • X / Twitter5 posts
  • Blogs5 articles
  • News3 articles
  • YouTube2 videos

AI synopsis

What people are saying

Discussions reflect a cautious interest, with some mentions of clinical trials like Epoetin use in CKD, highlighting the relevance of improving anemia management, though with a focus on standard research rather than groundbreaking findings. Words like 'trial' and 'results' suggest a technical tone, showing reader curiosity without overt enthusiasm.

AgreementNeither agree nor disagree

The discussions show mixed opinions; some posts are neutral or acknowledge the research without strong support or opposition.

InterestModerate interest

The topic of anemia treatment and kidney disease appears somewhat engaging to readers interested in medical advances.

EngagementModerate engagement

Posts include references to specific trials and the significance of the research, indicating moderate engagement.

ImpactNeutral impact

The overall perceived impact seems moderate, recognizing the importance of treatment strategies but without emphasizing revolutionary changes.

Abstract in brief

  • The study investigated whether correcting anemia in patients with stage 3 or 4 chronic kidney disease impacts cardiovascular outcomes.
  • Patients were divided into two groups: one aimed for a normal hemoglobin level and the other for a lower hemoglobin target.
  • Results showed no significant difference in cardiovascular events between the two groups, though the group with normal levels had better quality of life but faced more complications like hypertension.
Read the full abstract

Top posts

Most liked on X and Bluesky
Tejas Desai, MD, MBA
@nephondemand · X

• CREATE https://t.co/AAtFIDOUYE Randomized non-placebo trial of Epoetin in CKD 3-4

Jan 16, 2019 · 4 likes · 3 shares · 11,976 followers View post →
Anace Pastor ✨️ Renalis
@anace710 · X

RT @nephondemand: • CREATE https://t.co/AAtFIDOUYE Randomized non-placebo trial of Epoetin in CKD 3-4

Jan 17, 2019 · 3 shares · 1,894 followers View post →
Dr Theepa N.M.R
@TNesam · X

RT @nephondemand: • CREATE https://t.co/AAtFIDOUYE Randomized non-placebo trial of Epoetin in CKD 3-4

Jan 27, 2019 · 3 shares · 698 followers View post →
pharmacist
@pharmacistKAMO · X

慢性腎臓病および貧血患者におけるヘモグロビンレベルの正常化 PMID: 17108342 https://t.co/vghgB2FfK9

Aug 15, 2023 · 182 followers View post →

All mentions

pharmacist
@pharmacistKAMO · X

慢性腎臓病および貧血患者におけるヘモグロビンレベルの正常化 PMID: 17108342 https://t.co/vghgB2FfK9

Aug 15, 2023 · 182 followers View post →
Dr Theepa N.M.R
@TNesam · X

RT @nephondemand: • CREATE https://t.co/AAtFIDOUYE Randomized non-placebo trial of Epoetin in CKD 3-4

Jan 27, 2019 · 3 shares · 698 followers View post →
madree
@madrees007 · X

RT @nephondemand: • CREATE https://t.co/AAtFIDOUYE Randomized non-placebo trial of Epoetin in CKD 3-4

Jan 21, 2019 · 3 shares · 53 followers View post →
Anace Pastor ✨️ Renalis
@anace710 · X

RT @nephondemand: • CREATE https://t.co/AAtFIDOUYE Randomized non-placebo trial of Epoetin in CKD 3-4

Jan 17, 2019 · 3 shares · 1,894 followers View post →
Tejas Desai, MD, MBA
@nephondemand · X

• CREATE https://t.co/AAtFIDOUYE Randomized non-placebo trial of Epoetin in CKD 3-4

Jan 16, 2019 · 4 likes · 3 shares · 11,976 followers View post →